Evidence map›Paper›PMID 39588433›Full record

ReviewCureus2024

An Integrated Pathophysiological and Clinical Perspective of the Synergistic Effects of Obesity, Hypertension, and Hyperlipidemia on Cardiovascular Health: A Systematic Review.

Pedro Okoh, Damilare A Olusanya, Okechukwu C Erinne, Kosisochi E Achara, Abiodun O Aboaba, Rejoice Abiodun, Grace A Gbigbi-Jackson, Rejoice F Abiodun, Adebimpe Oredugba, Ron Dieba and 1 more

Abstract readReview
In one paragraph

Review in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Pedro OkohEmergency Medicine, Lancashire Teaching Hospital, Preston, GBR.
Damilare A OlusanyaGeneral Medicine, West Suffolk Hospital, Bury Saint Edmunds, GBR.
Okechukwu C ErinneEpidemiology, University of Texas Health Science Center at Houston, Houston, USA.
Kosisochi E AcharaPublic Health, Emory University, Georgia, USA.
Abiodun O AboabaFamily and Community Medicine, Avalon University School of Medicine, Madisonville, USA.
Rejoice AbiodunDepartment of Obstetrics and Gynecology, St. Ann's Bay Regional Hospital, St. Ann's Bay, JAM.
Grace A Gbigbi-JacksonFamily Medicine, All Saints University School of Medicine, Roseau, DMA.
Rejoice F AbiodunInternal Medicine, Spartan Health Sciences University, Vieux Fort, JAM.
Adebimpe OredugbaInternal Medicine, Lister Hospital, East and North Hertfordshire NHS Trust, Hertfordshire, GBR.
Ron DiebaFamily Medicine, International University of the Health Sciences, Toronto, CAN.
Okelue E OkobiFamily Medicine, Medficient Health Systems, Laurel, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This review paper explores the synergistic effects of obesity, hypertension (HTN), and hyperlipidemia on cardiovascular health by integrating pathophysiological and clinical perspectives. Obesity, characterized by excessive body fat, HTN, defined by elevated blood pressure, and hyperlipidemia, indicated by high blood lipid levels, are globally prevalent conditions that significantly increase the risk of cardiovascular diseases (CVDs). The interplay between these conditions exacerbates cardiovascular risk through mechanisms such as chronic inflammation, insulin resistance, endothelial dysfunction, arterial stiffness, and atherogenesis. This review synthesizes epidemiological evidence and highlights the prevalence and co-occurrence of these conditions, with an emphasis on their combined impact on cardiovascular health. The literature search encompassed various databases, and data extraction included key study characteristics and outcomes. The findings underscore the importance of integrated management strategies, involving lifestyle interventions, pharmacological treatments, and regular monitoring, to mitigate the heightened cardiovascular risk posed by these conditions. In addition, the various public health implications are addressed, advocating for community-based interventions and policy changes. Future research directions may include exploring novel therapeutic approaches, personalized medicine strategies, and longitudinal studies to enhance the understanding and management of the synergistic effects of obesity, HTN, and hyperlipidemia on cardiovascular health.

Indexed as

cardiovascular healthhyperlipidemiahypertensioninsulin resistanceobesity

Identifiers

PMID39588433
PMCPMC11588357

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.